Cimlanod
Cimlanod Uses, Dosage, Side Effects, Food Interaction and all others data.
Cimlanod is under investigation in clinical trial NCT02819271 (A First-in-Human Study of the Safety of Single Continuous Intravenous (IV) Infusions of CXL-1427 for up to 48 Hours in Healthy Volunteers).
Trade Name | Cimlanod |
Generic | Cimlanod |
Cimlanod Other Names | BMS-986231, Cimlanod |
Type | |
Formula | C5H7NO4S |
Weight | Average: 177.17 Monoisotopic: 177.009578883 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Cimlanod